| # | Drug | Count |
|---|---|---|
| 0 | IBRUTINIB | 24 |
| 1 | RITUXIMAB | 23 |
| 2 | DEXAMETHASONE | 13 |
| 3 | DEXAMETHASONE 1.5 MG | 13 |
| 4 | METHOTREXATE SODIUM | 12 |
| 5 | METHOTREXATE | 10 |
| 6 | CYCLOPHOSPHAMIDE | 6 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 6 |
| 9 | BORTEZOMIB | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORAMBUCIL | 2 | 0.0005 |
| 1 | ZANUBRUTINIB | 2 | 0.0004 |
| 2 | IBRUTINIB | 24 | 0.0003 |
| 3 | BENDAMUSTINE HCL | 4 | 0.0003 |
| 4 | RITUXIMAB | 23 | 0.0001 |
| 5 | MEPERIDINE HYDROCHLORIDE | 1 | 0.0001 |
| 6 | DEXAMETHASONE SODIUM PHOSPHATE | 1 | 0.0001 |
| 7 | CYTARABINE | 5 | 0.0001 |
| 8 | THEOPHYLLINE ANHYDROUS | 1 | 0.0001 |
| 9 | BORTEZOMIB | 5 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 26 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 23 |
| 2 | Corticosteroid [EPC] | 17 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 4 | Alkylating Drug [EPC] | 6 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 5 |
| 6 | Proteasome Inhibitor [EPC] | 5 |
| 7 | Benzodiazepine [EPC] | 3 |
| 8 | Anti-epileptic Agent [EPC] | 2 |
| 9 | BCL-2 Inhibitor [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 23 | 0.0001 |
| 1 | Kinase Inhibitor [EPC] | 26 | 0.0000 |
| 2 | Proteasome Inhibitor [EPC] | 5 | 0.0000 |
| 3 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 4 | BCL-2 Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 6 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 10 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 9 | Methylxanthine [EPC] | 1 | 0.0000 |